Clinical Trial Update: A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 study investigates epothilone D with Herceptin (trastuzumab) in HER-2 positive advanced or metastatic breast cancer; study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Epothilone D (epothilone D)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED